Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Colorectal Cancer Clinical Trials

Review the colorectal cancer clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 351-375 of 435

An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
An Imaging Agent ([18F]FETrp) with Positron Emission Tomography/Computed Tomography for Visualizing Brain, Breast, and Neuroendocrine Tumors
Status: Active
Location: Wayne State University/Karmanos Cancer Institute, Detroit, Michigan
Ultrasound for the Diagnosis of Oxaliplatin-Induced Peripheral Neuropathy in Patients with Gastrointestinal Cancer
Status: Active
Location: Wake Forest University Health Sciences, Winston-Salem, North Carolina
Intravital Microscopy in Human Solid Tumors
Status: Active
Location: Mayo Clinic in Florida, Jacksonville, Florida
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
Status: Active
Location: Massachusetts General Hospital Cancer Center, Boston, Massachusetts
Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in Gastrointestinal Cancer, PERICLES Study
Status: Temporarily Closed to Accrual
Location: 2 locations
18F-alphavbeta6-Binding-Peptide PET Scan in Imaging Patients with Primary or Metastatic Cancer in the Breast, Colorectal, Lung, or Pancreas
Status: Temporarily Closed to Accrual
Location: University of California Davis Comprehensive Cancer Center, Sacramento, California
A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
Status: Active
Location: 5 locations
The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer
Status: Active
Location: 3 locations
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Status: Active
Location: Stanford Cancer Institute Palo Alto, Palo Alto, California
Evaluating Whether an Educational Website called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Status: Active
Location: 340 locations
CARES Intervention for the Improvement of Timeliness and Quality of Care in Rural Cancer Patients with Solid Tumors
Status: Active
Location: 12 locations
Video Education with Result Dependent Disclosure to Improve Genetic Testing Uptake and Patient Outcomes, VERDI Study
Status: Active
Location: 8 locations
Patient Navigation Program in Supporting Underrepresented Minorities with Advanced Gastrointestinal, Hematologic, or Thoracic Cancer in Genomic-Based Cancer Trial Enrollment, The SURGE Trial
Status: Active
Location: 3 locations
Virtual Health Insurance Education Program (CHAT-S) for Improving Health Insurance Literacy and Surveillance in Young Adult Cancer Survivors
Status: Active
Location: 2 locations
A Digital Health Tool for Improving Knowledge and Uptake of Genetic Testing among Black Cancer Survivors
Status: Active
Location: 2 locations
Shared Decision-Making Aid Impact on Colorectal Cancer Screening Behaviors in Older Adults with Low Health Literacy
Status: Active
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy after Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Facilitation of Cancer Prevention and Screening Guideline Implementation in Primary Care Settings
Status: Active
Location: University of Kentucky/Markey Cancer Center, Lexington, Kentucky
A Web-Based Decision Aid for Return of Genomic Results to Patients with Cholangiocarcinoma, Multiple Myeloma, or Colorectal Cancer
Status: Active
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri
Patient Engagement in Cancer Genome Sequencing, WU-PE-CGS Trial
Status: Active
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri
A Patient-Caregiver Behavioral Intervention (COPE+) for the Support of Cancer Patients with Mild Cognitive Impairment
Status: Active
Location: Duke University Medical Center, Durham, North Carolina
A Patient Intervention to Reduce the Financial Burden of Cancer, the DISCO Study
Status: Active
Location: Wayne State University/Karmanos Cancer Institute, Detroit, Michigan
A Support Program (BOLSTER) for the Improvement of Quality of Life in Metastatic Gynecologic or Gastrointestinal Cancer Patients with Complex Care Needs and their Caregivers, BOLSTER Trial
Status: Active
Location: 2 locations
Association between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-Cancer Patients
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas